MiniMed Group Inc (NASDAQ:MMED) Stock Rated “Moderate Buy” by Sell-Side Brokerages
by Michael Walen · The Markets DailyShares of MiniMed Group Inc (NASDAQ:MMED – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nineteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year target price among brokers that have covered the stock in the last year is $24.25.
MMED has been the topic of a number of research analyst reports. Rothschild & Co Redburn began coverage on MiniMed Group in a research note on Tuesday, October 13th. They issued a “buy” rating and a $30.00 target price on the stock. UBS Group boosted their price objective on MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Weiss Ratings upgraded MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a research note on Wednesday, September 9th. Bank of America lifted their target price on MiniMed Group from $24.00 to $28.00 and gave the stock a “buy” rating in a research note on Wednesday, September 2nd. Finally, BTIG Research boosted their price target on shares of MiniMed Group from $25.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, September 1st.
Get Our Latest Research Report on MiniMed Group
Hedge Funds Weigh In On MiniMed Group
Several hedge funds have recently bought and sold shares of MMED. State of Alaska Department of Revenue bought a new position in MiniMed Group during the 3rd quarter worth approximately $227,000. State Street Corp bought a new position in shares of MiniMed Group in the second quarter worth approximately $6,029,000. The Manufacturers Life Insurance Company purchased a new position in shares of MiniMed Group in the second quarter worth $185,000. WINTON GROUP Ltd bought a new stake in MiniMed Group during the 2nd quarter valued at $273,000. Finally, Engineers Gate Manager LP purchased a new stake in MiniMed Group during the 2nd quarter valued at $513,000.
MiniMed Group Trading Up 0.3%
Shares of MMED stock opened at $18.34 on Friday. The firm has a 50-day moving average of $20.32 and a 200-day moving average of $16.62. MiniMed Group has a one year low of $10.65 and a one year high of $24.43.
MiniMed Group Company Profile
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.
Featured Stories
- Five stocks we like better than MiniMed Group
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat